GRX
NYSE:GRX
The Gabelli Healthcare & Wellness Trust
- Stock
Last Close
9.25
06/11 21:10
Market Cap
151.68M
Beta: -
Volume Today
29.11K
Avg: 29.55K
PE Ratio
−3.49
PFCF: 2.85
Dividend Yield
6.22%
Payout:−34.71%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||
average payables | 402.31K - | 391.43K 2.70% | 2.11M 438.54% | 4.94M 134.22% | 4.88M 1.19% | 1.76M 63.85% | ||
average receivables | 2.62M - | 387.96K 85.19% | 2.74M 607.33% | 2.79M 1.77% | 3.55M 27.17% | 3.70M 4.17% | ||
book value per share | 17.26 - | 14.54 15.72% | 17.94 23.37% | 15.49 13.68% | 15.32 1.11% | 11.58 - | ||
capex per share | ||||||||
capex to depreciation | ||||||||
capex to operating cash flow | ||||||||
capex to revenue | ||||||||
cash per share | 0.00 - | 0.00 - | 0.00 - | |||||
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 54.37 - | -94.64 274.07% | 2.57 102.72% | 74.58 2,798.52% | 3.99 94.64% | -51.78 1,396.10% | 18.00 134.76% | |
debt to assets | 0.00 - | 0.00 - | 0.22 - | |||||
debt to equity | 0.00 - | 0.00 - | 0.29 - | |||||
dividend yield | 0.06 - | 0.07 26.68% | 0.07 - | |||||
earnings yield | 0.18 - | -0.01 107.52% | 0.27 2,152.43% | 0.13 52.20% | 0.18 41.21% | 0.00 - | ||
enterprise value | 180.60M - | 172.76M 4.34% | 196.33M 13.64% | 186.84M 4.83% | 233.93M 25.20% | -50.49K 100.02% | 202.19M 400,587.44% | |
enterprise value over ebitda | 5.70 - | -75.81 1,430.11% | 3.69 104.87% | 7.73 109.20% | 5.47 29.16% | 0.00 99.98% | 63.10 5,532,417.47% | |
ev to operating cash flow | 4.13 - | -12.35 398.97% | -0.00 99.99% | -567.19 65,289,406.81% | ||||
ev to sales | 5.56 - | -112.85 2,130.82% | 3.65 103.24% | 7.47 104.59% | 5.38 28.01% | 0.00 99.98% | 12.91 1,194,488.73% | |
free cash flow per share | 2.89 - | -1.10 138.00% | -0.02 - | |||||
free cash flow yield | 0.24 - | -0.08 133.46% | -0.00 - | |||||
graham net net | 0.15 - | -0.02 114.01% | -0.02 18.25% | 0.01 175.53% | -5.02 39,618.68% | -3.36 - | ||
graham number | 26.62 - | 6.32 76.26% | 35.48 461.55% | 23.21 34.58% | 29.23 25.93% | 2.63 - | ||
income quality | 2.10 - | -0.44 121.14% | -1.22 176.36% | -0.84 31.17% | ||||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 337.12K - | -19.48K 105.78% | 418.52 - | 22.06 94.73% | -13.93 163.15% | 1.15 108.22% | ||
interest debt per share | 0.00 - | 0.00 131.45% | 0.00 - | 0.12 3,050.40% | 3.52 - | |||
inventory turnover | ||||||||
invested capital | 0.00 - | 0.00 - | 0.29 - | |||||
market cap | 180.60M - | 172.77M 4.34% | 196.33M 13.63% | 186.85M 4.82% | 233.86M 25.16% | 148.87M - | ||
net current asset value | 3.76M - | -285.03K 107.58% | -191.91K 32.67% | 1.48M 869.12% | -86.41M 5,954.23% | -37.37M 56.76% | -54.23M 45.14% | |
net debt to ebitda | 0.00 - | -0.00 - | 0.00 428.85% | 0.00 28.84% | 16.64 1,458,838.25% | |||
net income per share | 1.82 - | -0.12 106.69% | 3.12 2,656.11% | 1.55 50.42% | 2.48 60.36% | 0.03 - | ||
operating cash flow per share | 2.89 - | -1.10 138.00% | -0.02 - | |||||
payables turnover | ||||||||
receivables turnover | 6.71 - | -3.86 157.45% | 141.86 3,778.28% | 4.89 96.55% | 91.37 1,766.90% | -7.05 107.72% | 20.28 387.68% | |
research and ddevelopement to revenue | ||||||||
return on tangible assets | 0.11 - | -0.01 107.94% | 0.17 2,168.70% | 0.08 51.25% | 0.12 44.33% | -0.19 256.59% | 0.00 100.93% | |
revenue per share | 1.87 - | -0.08 104.38% | 3.15 3,948.29% | 1.60 49.30% | 2.52 57.80% | 0.98 - | ||
roe | 0.11 - | -0.01 107.93% | 0.17 2,171.97% | 0.10 42.56% | 0.16 62.16% | -0.23 243.17% | 0.00 100.99% | |
roic | 0.11 - | -0.01 107.93% | 0.17 2,172.08% | 0.10 42.56% | 0.16 62.12% | -0.22 233.61% | 0.01 106.22% | |
sales general and administrative to revenue | 0.03 - | -0.49 2,054.34% | 0.01 102.29% | 0.03 194.46% | 0.02 47.50% | -0.02 190.22% | ||
shareholders equity per share | 17.26 - | 14.54 15.72% | 17.94 23.37% | 15.49 13.68% | 15.32 1.11% | 11.58 - | ||
stock based compensation to revenue | ||||||||
tangible asset value | 299.68M - | 271.65M 9.35% | 306.46M 12.82% | 282.85M 7.71% | 263.95M 6.68% | 204.65M 22.47% | 184.81M 9.70% | |
tangible book value per share | 17.26 - | 14.54 15.72% | 17.98 23.64% | 18.09 0.59% | 15.32 15.33% | 11.58 - | ||
working capital | 4.25M - | 191.23K 95.50% | -191.91K 200.36% | 1.48M 869.12% | -5.75M 489.81% | 3.15M 154.74% | -384 100.01% |
All numbers in USD (except ratios and percentages)